Skip to Content
Merck
CN
  • [Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

[Role of rifaximin in correction of IBS-like symptoms in patients with inflammatory bowel disease].

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology (2013-12-04)
S S Belous, I L Khalif, O V Golovenko
PMID24294774
ABSTRACT

One of the important problems in the treatment of patients with inflammatory bowel disease are the persistent complaints of pain, abdominal distention, frequent stools, excretion of mucus with faeces with the presence of endoscopic or roentgenologic remission in the damaged parts of gastrointestinal tract. In this review we describe possible causes of such complaints and some methods of their therapeutic correction.